Manganese (Mn), one of the more abundant metals on Earth, acts as an essential cofactor of multiple enzymes. Mn occurs naturally in most foods and Mn deficiency in humans is therefore rare; however, elevated levels of Mn can occur due to a rare inherited genetic disorder (hypermanganesemia) or as a consequence of environmental Mn exposure ([@kfv252-B27]). Toxic exposure to Mn can occur in occupational settings such as in the welding, ferroalloy, and mining industries ([@kfv252-B26]; [@kfv252-B39], [@kfv252-B38]; [@kfv252-B42]), through exposure to contaminated soil and house dust in the vicinity of ferroalloy industries ([@kfv252-B24]; [@kfv252-B25]; [@kfv252-B34]), or from ingestion of contaminated ground water ([@kfv252-B43]). Elevated environmental exposure to Mn has been associated with cognitive, behavioral, and neuromotor deficits in children ([@kfv252-B51]). Mn can accumulate in the brain and cause neurological disturbances in adults (referred to as manganism), with symptoms resembling those of Parkinson's disease ([@kfv252-B6]).

Physiological Mn levels are regulated by homeostatic mechanisms. Epithelial cells in the intestine or lungs take up Mn, which enters the blood circulation; from there, it can cross the blood-brain barrier ([@kfv252-B27]). Mn may also enter the brain directly through the olfactory pathways ([@kfv252-B11]; [@kfv252-B47]). The liver clears excess Mn, which is excreted via the bile. Several metal transporters are involved in the transport of Mn across the cell membrane, including the divalent metal transporter 1 ([@kfv252-B7], [@kfv252-B6]), but the system that regulates Mn homeostasis has not been entirely elucidated.

Recent research has linked mutations in the solute carrier family 30 member 10 (*SLC30A10*) on chromosome 1, which was originally identified as a zinc (Zn)-transporter ([@kfv252-B45]), to inherited forms of hypermanganesemia, in which patients with adequate Mn intake accumulate Mn in the liver and brain ([@kfv252-B36], [@kfv252-B37]; [@kfv252-B48]). The link between SLC30A10 and Mn levels was also highlighted in a recent genome-wide association study in which genetic variation associated with serum Mn levels was mapped to *SLC30A10* ([@kfv252-B33]). Moreover, Mn induced up-regulation of SLC30A10 protein in cell culture ([@kfv252-B36]) and expression of human wild-type *SLC30A10* in yeast (*Saccharomyces cerevisiae*) allowed the cells to grow in high-Mn conditions ([@kfv252-B48]), further supporting the role of SLC30A10 as a key regulator of Mn homeostasis. The SLC30A10 protein, which localizes at the cell surface, protects the cell against toxic Mn levels by functioning as an Mn efflux transporter ([@kfv252-B21]). *SLC30A10* expression is high in liver, intestines, and the central nervous system (IST online; <http://ist.medisapiens.com>), all organs involved in Mn transport and regulation.

Blood Mn concentrations vary over the human lifespan (declining from birth into adulthood), and during periods of heightened nutritional demand, such as pregnancy; individuals also show substantial variation. We hypothesized that part of the observed individual variation in blood Mn concentrations is due to genetic variation in the gene encoding the SLC30A10 transporter. To explore this individual variation, we genotyped 2 common *SLC30A10* single nucleotide polymorphisms (SNPs) in 3 unrelated cohorts of adults with different Mn exposures. We also evaluated the influence of *SLC30A10* genotypic variance on neurological function.

MATERIALS AND METHODS
=====================

### Study Cohorts

In this study we used data from 3 independent cohorts from different parts of the world to evaluate the impact of genotypic variation on Mn concentrations in blood.

#### Bangladesh cohort

The study cohort from Bangladesh consists of pregnant women living in the rural area of Matlab, 53 km southeast of Dhaka, where the International Centre for Diarrhoeal Disease Research in Bangladesh (icddr,b) has a well-established Health and Demographic Surveillance System. The study was nested into a randomized food and micronutrient supplementation trial (MINIMat) conducted during pregnancy. In this region, well water often contains elevated arsenic concentrations, and thus, studies concerning the potential health effects of arsenic exposure in early life were nested in the MINIMat trial ([@kfv252-B49]). To avoid the arsenic, deeper wells are constructed; however, the water from these wells often contains elevated concentrations of Mn \[median Mn value in drinking water was 228 µg/l (range 10--6336)\] ([@kfv252-B23]; [@kfv252-B40]). The study cohort and sampling procedures have been described in detail ([@kfv252-B17], [@kfv252-B18]). Blood samples were collected in 5.5-ml Li-heparin tubes at gestational week 14. Mn, Zn, and ferritin concentrations have been published previously ([@kfv252-B18]; [@kfv252-B23]). In this study, we used data from 406 women for which Mn concentrations and DNA samples were available.

#### Argentinean Andes cohort

The Andean cohort consists of 202 subjects (284 women and 18 men) from the San Antonio de los Cobres village and surrounding smaller villages in the northern Argentinean Andes (altitude around 4000 m). These subjects participated in a cross-sectional study of the health effects of toxic elements (primarily arsenic and lithium) in drinking water ([@kfv252-B1]; [@kfv252-B4]). This region has low levels of Mn in drinking water (\<5 µg/l) ([@kfv252-B9]). Peripheral blood samples were collected in vacutainers with EDTA anticoagulant for Mn analysis and DNA extraction for genotyping analysis. From the 202 subjects, 198 DNA samples were available for genotyping.

#### Italian cohort

This cohort has previously been described in detail ([@kfv252-B28]). It consists of 238 elderly people (107 men and 131 women) aged 65--76 years, residing in the province of Brescia, Italy, with varying degrees of environmental Mn exposure due to historic emissions from ferroalloy foundries in the area. The Valcamonica valley (*n* = 146 subjects), in which 3 ferroalloy plants operated for a century (until 2001), has been studied as an area of Mn exposure. The Garda Lake area (*n* = 92 subjects), with no history of ferroalloy industrial activity, has been used as a reference area. The median Mn level in soil for Valcamonica was 923 mg/kg (range 473--1724 mg/kg) and for the Garda Lake region was 410 mg/kg (range 313--549 mg/kg) ([@kfv252-B28]). A significantly higher prevalence of Parkinsonism associated with Mn levels in settled dust was previously reported for Valcamonica ([@kfv252-B25]). All subjects underwent extended neurological testing of motor, cognitive, sensory, and behavioral functions. None of the subjects was a confirmed patient or had a medically proven diagnosis of Parkinson's disease or any similar symptoms. Blood samples were collected from study participants in EDTA vacutainers for analysis of Mn and subsequent DNA extraction and genotyping ([@kfv252-B41]). From the 238 subjects, 232 DNA samples were available for genotyping.

Ethical Considerations
----------------------

The studies were approved by the research and ethical review committees at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) in Dhaka, the Ethical Committee of the Local Public Health Agency of Brescia and the Ethical Committee at Karolinska Institutet, Sweden. The procedures were in accordance with the Helsinki Declaration.

Analysis of Markers in Blood
----------------------------

Blood Mn concentrations were measured in erythrocyte preparations (Ery-Mn) from the Bangladeshi women and whole blood from the Andean cohort, using inductively coupled mass spectrometry (ICP-MS) (Agilent 7500ce, Agilent technologies, Tokyo, Japan) at the Karolinska Institutet, Stockholm. Prior to ICP-MS, samples were processed by microwave-assisted UltraClave to obtain carbon-free samples ([@kfv252-B23]). For the Italian cohort, Mn concentrations were measured in whole blood by atomic absorption spectroscopy (AAS) at the Laboratory of Industrial Toxicology of the University of Brescia. To enable comparison of Mn levels between cohorts, blood Mn concentrations in the Andean and Italian cohorts were converted to Ery-Mn. For this calculation, we estimated that 66% of Mn in blood is bound to erythrocytes ([@kfv252-B32]) and that the density of the erythrocyte preparations was 1.055 g/ml. The volume fraction of erythrocytes in total blood for each individual was estimated by dividing their hemoglobin levels with the reference value of erythrocyte mean hemoglobin content of 340 g/l ([@kfv252-B20]; [@kfv252-B31]). Median hemoglobin levels were 155 g/l (131--183 g/l, 5--95 percentile) and 141 g/l (125--162 g/l, 5--95 percentile) in the Andean and Italian cohorts, respectively.

Plasma Zn was measured by spectrophotometry in the Andean samples (accredited method, LOD 0.6 µmol/l) and by AAS in the Bangladeshi samples ([@kfv252-B18]; [@kfv252-B22]). Plasma Zn was not measured in the Italian cohort.

Ferritin is the main iron (Fe) storage protein and plasma ferritin levels were measured as a proxy of nutritional iron status. Plasma ferritin was measured by immunoassay (Cobas e601; Roche Diagnostics, Mannheim, Germany) for the Andean samples, radioimmunoassay (Diagnostic Products, San Diego, California) for the Bangladeshi samples ([@kfv252-B18]; [@kfv252-B22]), and chemiluminescent microparticle immunoassay using the Architect SR 2000 Immunoassay Analyser (Abott Diagnostics, Illinois) for the Italian samples. Other Fe indicators included whole blood Fe in the Andean cohort measured by ICP-MS (Agilent), serum Fe in the Italian cohort measured using the Siemens Vista 500 (Siemens, Munich, Germany), and hemoglobin (Hb) measured in the Andean cohort using the Beckman Coulter LH 780 hematology analyzer (Beckman Coulter, Brea, California) and in the Italian using the HemoCue instrument (HemoCue, Ängelholm, Sweden).

Genotyping
----------

*SLC30A10* has no coding SNPs (GeneBank accession number: NG_032153.1) with sufficient minor allele frequencies for genotyping analysis. There was also insufficient genotyping data for *SLC30A10* from the HapMap3 database (<http://hapmap.ncbi.nlm.nih.gov/index.html.en>) for the identification of tag SNPs. To select SNPs for the study, we therefore selected 6 non-coding SNPs in *SLC30A10* (rs1776050, rs2275706, rs2275707, rs6663638, rs7525274, and rs12064812), with minor allele frequencies of \>5% in Asian populations (NCBI, <http://www.ncbi.nlm.nih.gov/>) and genotyped them in the Bangladeshi cohort. SNPs for further analyses were selected from this data based on linkage disequilibrium (LD) analysis using the Haploview software ([@kfv252-B3]) ([Supplementary Figure 1](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1)) as well as association analysis between genotypes and blood Mn concentrations. All SNPs showed weak associations with blood Mn concentrations, except for rs2275706, which was therefore not selected for further analysis. Rs2275707 (A/C) showed strong linkage with rs1776050, rs6663638, and rs7525274, and was therefore selected as a tag SNP. Rs12064812 (T/C) was also chosen for further analysis since it could represent a different LD-block.

For genotyping, DNA was extracted from peripheral blood samples using the QIAamp DNA Blood Mini kit (Qiagen, Hilden, Germany). Genotyping was performed by allelic discrimination on the ABI 7900HT instrument using TaqMan SNP genotyping assays (Life Technologies, Carlsbad, California) and TaqMan Universal Mastermix (UNG free, no AmpErase; Life Technologies). Assay information is summarized in [Supplementary Table 1](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1). The following PCR conditions were applied: 10 min at 95°C followed by 45--50 cycles of 15 s at 92°C, and 90 s at 60°C. PCR amplifications were conducted in 96-well plates with negative controls (water) included on each plate. To ensure reproducibility and accuracy of genotyping data, 5% of samples were re-analyzed in a separate round of experiments. Deviation from the Hardy-Weinberg equilibrium was evaluated using chi-square analysis.

Gene Expression Analysis
------------------------

For a sub-group of the Andean cohort (*N* = 101), all female and including no first-degree relatives, blood was also collected in PAX tubes (PreAnalytiX GmbH, Hombrechtikon, Switzerland) and stored at −20°C for RNA extraction and subsequent gene expression analysis. RNA was extracted using the PAXgene Blood RNA kit (PreAnalytiX GmbH, Hombrechtikon, Switzerland) and stored at −80°C. RNA concentrations and purities were evaluated on a Nanodrop spectrophotometer (Wilmington, Delaware). Adequate RNA integrity (RNA integrity number \>7.5) was confirmed using a Bioanalyzer 2100 (Agilent, Santa Clara, California). RT-PCR was performed using the High-Capacity cDNA reverse transcription Kit (Life Technologies) in 20 µl reaction volumes with input RNA in the range of 150--600 ng. Expression analysis was performed by real-time PCR using TaqMan Gene Expression Assays (list of assay IDs are presented in [Supplementary Table 2](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1)) and TaqMan Gene Expression Mastermix from Life Technologies. Reactions were run on the ABI 7900-HT Fast Real Time PCR instrument (Life Technologies) in a total volume of 10 µl using 1 µl of cDNA. Initially, a set of reference genes (*2,4-Dienoyl CoA Reductase1DECR1*; *Folylpolyglutamate Synthase*; and *Hypoxanthine Phosphoribosyltransferase 1*) was evaluated for stable expression in 20 RNA samples extracted from blood. *DECR1* showed the smallest variation of expression between samples \[standard deviation of 0.32 cycle threshold (*C*~t~)\] for which the same RNA input had been used and was therefore selected as a reference gene for calculation of relative expression levels using the delta *C*~t~ method. *DECR1* has previously been described as a suitable reference gene for gene-expression analysis in blood ([@kfv252-B46]). Due to low expression levels of *SLC30A10* in blood, some samples did not generate useful data. Samples were selected for further analysis based on the criteria that 2 out of 3 triplicates had to generate a signal and that the replicates had to deviate by \<1.5 *C*~t~. Negative controls (water) did not generate any signal.

Analysis of Neurological Parameters (*Italian* Cohort Only)
-----------------------------------------------------------

To assess psychomotor speed, finger tapping was measured using the Finger Tapping test, computerized version from the SPES ([@kfv252-B13]). The task of the participant is to tap a push-button alternatively with the dominant and non-dominant hand over the 5-min test duration.

Body sway (motor-balance) was recorded by placing the subject on a balance plate that produces signals from 3 sensors to map the position of the force center, using the Catsys Tremor 7.0 by Danish Product Development ([@kfv252-B10]), as previously described ([@kfv252-B29]). The center is defined as the center of equilibrium of the 3 vertical forces, which are recorded at the 3 supports of the sway plate. The sway plate is visualized on the computer screen and the journey of the force center can be observed in an *X-Y* coordinate system.

Bioinformatic Analysis of Gene-Regulatory Elements and Transcription
--------------------------------------------------------------------

The potential effects of the 2 SNPs on regulatory elements were examined in relation to signatures of gene-regulatory elements available from the UCSC Genome Browser ([www.genome.ucsc.edu](http://www.genome.ucsc.edu)), including H3K27Ac \[Histone H3 acetylation at Lys27 (7 cell lines from ENCODE); indicative of active regulatory regions\], DNaseI \[DNase I hypersensitive sites (125 cell types from ENCODE); indicative of open and active chromatin\], and TF \[transcription factor binding sites (ChIP-Seq of 161 factors 91 cell types combined)\]. Transcription factor analysis of different allelic variants was performed using MatInspector (Genomatix, Munich, Germany) with the vertebrate matrix and 75% matrix similarity filter. Non-coding RNA transcription and conserved miRNA binding sites were analyzed using data available from snoRNABase, miRBase, and TargetScanHuman 5.1 available via the UCSC Genome Browser. 3′UTR sequence motifs were searched for using UTRScan (<http://itbtools.ba.itb.cnr.it/utrscan>).

Statistical Analysis
--------------------

All statistical analyses were performed using unconverted whole-blood Mn concentrations for the Andean and Italian cohorts and Ery-Mn concentrations for the Bangladeshi cohort. Correlations between subject characteristics and markers in blood were performed using Spearman correlation coefficients. Associations between genotypes and Ery-Mn (Bangladesh), whole-blood Mn (Andes and Italy), plasma Zn (Bangladesh and Andes), *SLC30A10* expression levels in blood cells (Andes), and neurological parameters (sway velocity and finger tapping; Italy) were estimated using a multivariable-adjusted regression with the general linear model. Mn (dependent variable) was natural log (ln)-transformed to generate an improved distribution pattern, which was verified by Q-Q-plots. All analyses were performed with and without adjustments for age and sex, which were considered potential effect modifiers.

Iron status can influence Mn levels because Mn and Fe compete for the same cellular transporters ([@kfv252-B2]; [@kfv252-B7]; [@kfv252-B18]). Blood Mn and Fe are therefore often inversely correlated ([@kfv252-B23]). Associations of genotypes with Mn levels and *SLC30A10* expression levels were therefore also adjusted for Fe status. Ferritin (stored iron), which was measured in all 3 cohorts and showed the strongest correlations with Mn concentrations compared with other Fe indicators (see 'Results' section), was used as a proxy for Fe status in statistical analyses. However, since ferritin is upregulated in connection with inflammation ([@kfv252-B16]), we also evaluated association analyses using other Fe indicators that were available in the Andean and Italian cohorts, including Hb (both cohorts), whole blood Fe (Andean cohort), and plasma Fe (Italian cohort). We also performed the analysis of genotypes in association with Mn concentrations with adjustments for Zn; however, including Zn in the model caused a change of \<5% in the effect estimate and it was therefore excluded. Age and gender were also considered likely effect modifiers of neurological function due to the increase in Parkinson's-related symptoms with age and higher prevalence in men ([@kfv252-B15]).

*P*-value \< .05 denotes statistical significance. All statistical analyses were performed using SPSS (Version 20, Chicago, Illinois).

RESULTS
=======

Cohort Characteristics and Correlations
---------------------------------------

Descriptive characteristics and data on relevant markers in blood are summarized in [Table 1](#kfv252-T1){ref-type="table"}. Concentrations of Hb, serum Fe, and whole blood Fe are presented in [Supplementary Table 3](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1). Correlations between subject characteristics and markers in blood for all cohorts, as well as *SLC30A10* gene-expression levels (Andean sub-group only) and neurological parameters (Italian cohort only), are presented in [Supplementary Tables 4--7](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1). TABLE 1.Characteristics of Study CohortsBangladeshAndesItalyAllSub-group[^a^](#kfv252-TF1){ref-type="table-fn"}*N*Median (5--95 percentile)*N*Median (5--95 percentile)*N*Median (5--95 percentile)*N*Median (5--95 percentile)Women406--184--78--131--Men0--18------107--Age40426 (18--37)20234 (18--65)7832 (16--62)23869 (65--76)BMI39419.8 (16.6--24.8)20224.6 (18.8--35.0)7823.8 (18.2--35.0)----Whole blood[^b^](#kfv252-TF2){ref-type="table-fn"} Mn (µg/l)----20216.3 (10.8--26.4)7816.3 (10.8--30.0)2388.5 (5.0--15.6)Ery--Mn[^c^](#kfv252-TF3){ref-type="table-fn"} (µg/kg)40621.6 (13.3--35.1)20222.4 (14.2--40.7)7822.6 (14.5--41.3)23812.8 (7.6--23.7)Plasma ferritin (µg/l)40229.7 (8.0--88.0)19451.5 (8.0--336.0)7751.0 (5.9--279.7)238126 (23.9--372.6)Plasma Zn (mg/l)4020.56 (0.37--1.02)1220.79 (0.60--1.05)510.78 (0.65--1.10)----MAF[^d^](#kfv252-TF4){ref-type="table-fn"} rs2275707 (%)406C = 17.3196C = 24.775C = 24.7232C = 24.5MAF[^d^](#kfv252-TF4){ref-type="table-fn"} rs12064812 (%)406C = 40.6198C = 45.775C = 48.0232C = 29.0[^1][^2][^3][^4]

Compared with the Andean cohort (men and women), the Bangladeshi women were younger (median ages of 26 and 34 years, respectively) and had lower BMI (median 19.8 and 25.0 kg/m^2^, respectively). Whole-blood Mn values were higher in the Andean cohort than in the Italian cohort. Mn concentrations in erythrocytes (Ery-Mn; converted from whole blood concentrations for the Andean and Italian cohorts) were similar in the Bangladeshi and Andean cohorts and lower in Brescia. Plasma ferritin concentrations varied between cohorts with the lowest levels in the pregnant Bangladeshi women and the highest levels in the Italian cohort consisting of elderly men and women ([Table 1](#kfv252-T1){ref-type="table"}).

For Bangladeshi women, as previously described ([@kfv252-B23]), Mn concentrations in erythrocytes (Ery-Mn) at gestational week 14 were weakly inversely correlated with age (*r*~S~ = −0.13, *P* = .012) and plasma ferritin (*r*~S~ = −0.18, *P* \< .001) ([Supplementary Table 4](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1)). Inverse correlations were observed between whole-blood Mn concentrations and Fe indicators (blood/plasma Fe, and plasma ferritin) in the Andean and Italian cohorts and Hb in the Andean cohort (men and women), with the strongest correlations observed for plasma ferritin (*r*~S~ = −0.41, *P* \< .001 and *r*~S~ = −0.20, *P* = .002 in the Andes and Italy, respectively). There were no correlations for Mn and age in theses cohorts ([Supplementary Tables 5](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1) and [7](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1)).

Characteristics of SLC30A10 SNPs and Associated Sequences
---------------------------------------------------------

Minor allele frequencies for rs2275707 and rs12064812 are presented in [Table 1](#kfv252-T1){ref-type="table"}. Both SNPs were in Hardy-Weinberg equilibrium in all 3 cohorts (*χ*^2^ values are presented in [Supplementary Table 1](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1)). Due to low subject numbers for the rs2275707 rare variant allele homozygotes in all cohorts (\<7%), values for the variant homozygote (CC) and heterozygote (CA) genotypes were combined in the statistical analyses.

The rs2275707 (A/C) is located in the 3′UTR and rs12064812 (T/C) in the second intron of *SLC30A10* and these SNPs are 9.8 kb apart ([Figure 1](#kfv252-F1){ref-type="fig"}A). LD plot analyses of the 2 SNPs showed *R*^2^ values of 0.12, 0.27, and 0.13 in the Bangladeshi, Andean, and Italian cohorts, respectively. The potential of the 2 SNPs to affect post-transcriptional regulation by altering non-coding RNA transcription and/or miRNA binding was investigated by bioinformatics, but we did not observe any RNA transcription or conserved miRNA binding sites at the SNPs. We also tested whether rs2275707 coincided with any known 3′UTR sequence motifs involved in post-transcriptional regulation, but no such sites were found at the SNP. The possibility of the 2 SNPs being situated in regions involved in transcriptional regulation was also evaluated *in silico.* Both SNPs coincided with weak histone acetylation (H3K27Ac) and rs12064812 also coincided with a DNase I hypersensitivity site ([Figure 1](#kfv252-F1){ref-type="fig"}B). Transcription factor recognition site analysis showed differences between alleles for both SNPs. We also observed that the rs12064812 variant allele introduces a CpG site. The results are summarized in [Figure 1](#kfv252-F1){ref-type="fig"}B and [Supplementary Table 8](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1), which also includes information on function and gene-expression patterns of relevant transcription factors. FIG. 1.(A) Location of the SNPs rs2275707 and 12064812, in the *SLC30A10* gene and in relation to signatures of gene-regulatory elements available from the UCSC Genome Browser including Histone H3 acetylation at Lys27 (H3K27Ac), DNase I hypersensitive sites (DNase I), and transcription factor (TF) binding sites. (B) DNA sequences flanking the 2 SNPs, including changes of transcription factor binding sites between alleles (only TFs for which the SNP affected the core sequence are shown). For rs2275707, the rare variant (C) replaced a binding site for Hmx2/Nkx5-2 homeodomain transcription factor (HMX2) with an Ets variant 6 (ETV6) binding site. For rs12064812, the variant allele (C) introduced 2 TF recognition sites \[GDNF-inducible zinc finger protein 1 (GZ1F) and E2F transcription factor 3 (E2F3)\]. The CpG site for rs12064812 variant allele is marked with a box.

Association of SLC30A10 Genotypes with Mn and Zn Concentrations
---------------------------------------------------------------

Both SNPs showed an association with whole-blood Mn concentrations (natural log(ln)-transformed) in the Andean and Italian cohorts and although the strength of associations differed between cohorts, the directions were consistent ([Table 2](#kfv252-T2){ref-type="table"}, [Figure 2](#kfv252-F2){ref-type="fig"}A). The rs2275707 variant allele (C) was significantly associated with increased Mn concentrations. A similar but non-significant trend for the effect of genotype was observed for Ery-Mn in the Bangladeshi cohort ([Figure 2](#kfv252-F2){ref-type="fig"}A, [Table 2](#kfv252-T2){ref-type="table"}). The average increase in Mn concentrations for the heterozygotes and variant allele homozygotes combined (AC/CC) relative to the common allele homozygotes (AA) was 3.4%, 8.0%, and 10.6% in the Bangladeshi, Andean, and Italian cohorts, respectively. In contrast, the rs12064812 variant allele (C) appeared to have a negative influence on Mn concentrations in all 3 cohorts, but the association was significant only in Italy. The average decrease in Mn concentrations for the variant allele homozygotes (CC) relative to the common allele homozygotes (TT) was 5.1%, 6.7%, and 18.4% in Bangladesh, Andes, and Italy, respectively ([Table 2](#kfv252-T2){ref-type="table"}). The effect of both SNPs remained after adjusting for plasma ferritin, gender, and age ([Table 2](#kfv252-T2){ref-type="table"}). The associations also remained after adjustments for other Fe indicators (Hb, serum Fe, and blood Fe) ([Supplementary Table 9](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1)). FIG. 2.Associations of genotypes with Mn and *SLC30A10* expression. Error bars represent 95% confidence intervals (CI). Due to the low subject number for the rs2275707 variant homozygote genotype (\<5%), this was combined with the heterozygote genotype. (A) Associations of *SLC30A10* genotypes with blood Mn concentrations (represented by Ery-Mn in Bangladesh and whole blood Mn in the Andes and Italy). To enable comparison between populations, Mn levels are presented relative to levels for the homozygote genotype of the common allele, which was set to 1. The dashed line marks the reference level. (B) Associations of *SLC30A10* genotypes with gene-expression levels. *SLC30A10* expression is presented as % expression relative to the reference gene *DECR1.* The *P*-values are derived from the adjusted linear model (age, gender, and ferritin) with ln-transformed Mn levels. TABLE 2.Associations of Ery-Mn (Bangladeshi Cohort) and Whole-Blood Mn Concentrations (Andean and Italian Cohorts) with *SLC30A10* Genotypesrs2275707rs12064812AAAC/CCTTCTCCBangladesh*N*280126142199199% change[^a^](#kfv252-TF5){ref-type="table-fn"}--3.4--−5.2−5.1*P*[^b^](#kfv252-TF6){ref-type="table-fn"}0.3040.183*P*[^c^](#kfv252-TF7){ref-type="table-fn"}0.2070.168Andes*N*11086619344% change[^a^](#kfv252-TF5){ref-type="table-fn"}--8.0--−0.8−6.7*P*[^b^](#kfv252-TF6){ref-type="table-fn"}0.021[\*](#kfv252-TF8){ref-type="table-fn"}0.356*P*[^c^](#kfv252-TF7){ref-type="table-fn"}0.027[\*](#kfv252-TF8){ref-type="table-fn"}0.269**Italy***N*133991228624% change[^a^](#kfv252-TF5){ref-type="table-fn"}--10.6--1.8−18.4*P*[^b^](#kfv252-TF6){ref-type="table-fn"}0.016[\*](#kfv252-TF8){ref-type="table-fn"}0.028[\*](#kfv252-TF8){ref-type="table-fn"}*P*[^c^](#kfv252-TF7){ref-type="table-fn"}0.012[\*](#kfv252-TF8){ref-type="table-fn"}0.040[\*](#kfv252-TF8){ref-type="table-fn"}[^5][^6][^7][^8]

*SLC30A10* genotypes were also evaluated for associations with plasma Zn concentrations in the Bangladeshi and Andean cohorts to evaluate the potential of SLC30A10 as a Zn transporter ([Table 3](#kfv252-T3){ref-type="table"}). We did not observe any statistically significant associations between genotypes and plasma Zn concentrations in any of the cohorts before or after adjusting for age and gender. TABLE 3.Associations of Plasma Zinc Concentrations and *SLC30A10* Genotypes in the Bangladeshi and Andean Cohortsrs2275707rs12064812AAAC/CCTTCTCCBangladesh*N*27512814119965% change[^a^](#kfv252-TF9){ref-type="table-fn"}--3.6--1.08.3*P*[^b^](#kfv252-TF10){ref-type="table-fn"}0.3580.348*P*[^c^](#kfv252-TF11){ref-type="table-fn"}0.3510.471Andes*N*6452365625% change[^a^](#kfv252-TF9){ref-type="table-fn"}--0.6--0.142.1*P*[^b^](#kfv252-TF10){ref-type="table-fn"}0.8610.858*P*[^c^](#kfv252-TF11){ref-type="table-fn"}0.8350.851[^9][^10][^11]

SLC30A10 Genotypes and Gene Expression in the Andean Cohort
-----------------------------------------------------------

Transcript levels of *SLC30A10* in blood were very low with *C*~t~ values in the range of 35--38, and of the initial 101 mRNA samples, 78 generated data that could be used for further analysis. We did not observe any significant correlations between *SLC30A10* expression and Mn concentrations; however, we did observe a weak indication that gene expression could be inversely correlated with blood Mn (*r*~S~ = −0.18, *P* = .11) and the opposite trend was observed for ferritin (*r*~S~ = 0.18, *P* = .12) ([Supplementary Table 6](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1)).

The rs2275707 variant allele was significantly associated with reduced *SCL30A10* expression levels and we observed an average reduction of expression levels of 25% between common allele homozygotes (AA) and the combined group (AC/CC) ([Table 4](#kfv252-T4){ref-type="table"}, [Figure 2](#kfv252-F2){ref-type="fig"}B). In contrast, the rs12064812 variant allele showed a weak, non-significant trend toward increased *SLC30A10* expression ([Figure 2](#kfv252-F2){ref-type="fig"}B). TABLE 4.Associations of *SLC30A10* Expression and *SLC30A10* Genotypes in the Andean Sub-Grouprs2275707rs12064812AAAC/CCTTCTCC*N*4134173820% change[^a^](#kfv252-TF12){ref-type="table-fn"}--−24.6--3.926.8*P*[^b^](#kfv252-TF13){ref-type="table-fn"}0.029[^\*^](#kfv252-TF15){ref-type="table-fn"}0.329*P*[^c^](#kfv252-TF14){ref-type="table-fn"}0.029[^\*^](#kfv252-TF15){ref-type="table-fn"}0.334[^12][^13][^14][^15]

SLC30A10 Genotypes and Markers of Neurotoxicity in the Italian Cohort
---------------------------------------------------------------------

*SLC30A10* genotypes were further analyzed for their potential influence on neurological markers that are associated with Parkinsonism, including sway velocity (open and closed eyes) and finger tapping (dominant and non-dominant hand). None of the described neurological parameters showed correlations with blood Mn concentrations ([Supplementary Table 7](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1)).

The rs2275707 variant allele, which was associated with increased blood Mn, was also associated with increased sway velocity (average 15% increase) in the Italian cohort and the effect was significant for closed eyes ([Table 5](#kfv252-T5){ref-type="table"}). The significance increased somewhat after adjustments were made for age and gender.

The rs12064812 showed no significant associations with sway velocity. Instead, the variant allele, which was associated with lower blood Mn concentrations, was associated with increased finger-tapping performance. The strongest association observed for the non-dominant hand with an average increase in finger-tapping performance of 9% between the rs12064812 common and variant allele homozygotes. TABLE 5.Associations of Neurological Parameters and *SLC30A10* Genotypes in the Italian Populationrs2275707rs12064812AAAC/CCTTCTCCSway velocity (open eyes)*N*127861127823Group mean[^a^](#kfv252-TF16){ref-type="table-fn"}11.412.511.512.311.7% change[^b^](#kfv252-TF17){ref-type="table-fn"}--10.1--6.81.5*P*[^c^](#kfv252-TF18){ref-type="table-fn"}0.0830.528*P*[^d^](#kfv252-TF19){ref-type="table-fn"}0.0650.805Sway velocity (closed eyes)*N*127861127823Group mean[^a^](#kfv252-TF16){ref-type="table-fn"}15.417.715.617.117.2% change[^b^](#kfv252-TF17){ref-type="table-fn"}--15.0--9.710.0*P*[^c^](#kfv252-TF18){ref-type="table-fn"}0.0500.424*P*[^d^](#kfv252-TF19){ref-type="table-fn"}0.033[^\*^](#kfv252-TF20){ref-type="table-fn"}0.745Finger tapping (dominant hand)*N*132961198524Group mean[^a^](#kfv252-TF16){ref-type="table-fn"}47.747.846.049.351.0% change[^b^](#kfv252-TF17){ref-type="table-fn"}--0.4--7.110.8*P*[^c^](#kfv252-TF18){ref-type="table-fn"}0.8920.032[^\*^](#kfv252-TF20){ref-type="table-fn"}*P*[^d^](#kfv252-TF19){ref-type="table-fn"}0.8710.084Finger tapping (non-dominant hand)*N*132961198524Group mean[^a^](#kfv252-TF16){ref-type="table-fn"}44.445.242.946.746.7% change[^b^](#kfv252-TF17){ref-type="table-fn"}--1.93--8.98.7*P*[^c^](#kfv252-TF18){ref-type="table-fn"}0.5050.011[^\*^](#kfv252-TF20){ref-type="table-fn"}*P*[^d^](#kfv252-TF19){ref-type="table-fn"}0.4440.025[^\*^](#kfv252-TF20){ref-type="table-fn"}[^16][^17][^18][^19][^20]

Combined Analyses
-----------------

Since rs2275707 and rs12064812 influence Mn levels, and are not in LD, we also investigated the possibility of an interaction between the 2 SNPs. To address this, we performed association analysis combining genotypes for the 2 SNPs in the Italian cohort, where the associations were the strongest, and for which neurological variables were available. SNP interactions were evaluated for those outcome variables that were significantly associated with *SLC30A10* genotypes, ie, blood Mn concentrations, sway velocity (closed eyes), and finger tapping (non-dominant hand). To evaluate potential interactions, we assessed if combining genotypes would significantly affect the influence of genotypes on outcomes. For combined genotypes, the largest difference in blood Mn concentrations (2.3 µg/l) was observed between the combinations CC:TT to AA:CC (rs2275707:rs12064812) ([Supplementary Figure 2](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfv252/-/DC1)). The difference in Mn concentrations between the corresponding genotypes uncombined was 1.1 µg/l (rs2275707; CC to AA) and 1.7 µg/l (rs12064812; TT to CC). Since combining genotypes did not change the directions of associations, and the influence of combined genotypes on Mn concentrations was only marginally different compared with the additive effect of the corresponding genotypes uncombined, we concluded that that it is unlikely that the SNPs interact on blood Mn concentrations. Similar results were observed from combined genotype analysis for sway velocity and finger tapping.

DISCUSSION
==========

The SLC30A10 protein was recently implicated as an important and potentially specific Mn transporter based on the identification of mutations in *SLC30A10* as the causal factor of heritable neurological disorders, including hypermanganesemia, without any known excessive exposure to Mn ([@kfv252-B36], [@kfv252-B37]; [@kfv252-B48]). These individuals carried rare mutations in the coding region of *SLC30A10* that led to a truncation of the protein or amino acid substitutions which in turn resulted in impaired protein trafficking and severe failure of protein function ([@kfv252-B36]; [@kfv252-B48]). This is the first study in which common genetic polymorphisms in *SLC30A10* were studied in relation to blood Mn concentrations and Mn-related neurological outcomes in healthy individuals. In contrast to previously described functional mutations in *SLC30A10,* which are very rare and cause dramatic effects on protein function as well as internal Mn levels, we studied genetic variants that are present in the general populations and are associated with subtle changes in Mn blood concentrations. This is one of few studies to date investigating the influence of genetic polymorphisms on Mn regulation and transportation; while previous studies have focused mainly on genes in iron-related pathways ([@kfv252-B8]; [@kfv252-B12]), we here target a pathway of Mn homeostasis that appears to be independent of iron transport.

We found that the *SLC30A10* rs2275707 variant allele was associated with increased Mn and the rs12064812 variant allele was associated with decreased Mn concentrations. Although all cohorts did not show statistically significant associations between genotypes and Mn concentrations, the results are strengthened by the consistency in the directions of associations between the 3 cohorts, which are from very different ethnic backgrounds, have very different Mn exposures, and represent a wide range of internal Mn status. The Bangladeshi women showed the weakest associations of *SLC30A10* genotypes with Mn concentrations. Since Mn was measured in erythrocytes instead of whole blood in these women, the lower associations may reflect differences in Mn transport in different compartments of the blood. It is also possible that the weaker influence of *SLC30A10* genotypes in the Bangladeshi cohort is due to the lower nutritional status of members of this group, clearly indicated by their markedly lower BMI, and to pregnancy. These conditions may cause a general up-regulation of several transporters involved in Mn uptake ([@kfv252-B19]), which might diminish the individual effect of *SLC30A10.*

The rs2275707 variant allele (C), which was significantly associated with increased blood Mn concentrations, was also associated with reduced *SLC30A10* expression levels. This is consistent with the findings of Quadri *et al.*, who showed that a mutation that removed a large part of the SLC30A10 protein and nearly depleted SLC30A10 immunoreactivity in the liver was associated with higher blood Mn levels ([@kfv252-B36]). In contrast to rs2275707, the rs12064812 variant allele was associated with lower Mn blood concentrations. In line with this, we also observed a weak trend toward increased *SLC30A10* expression for this allele. Expression levels of *SLC30A10* in blood were very low and the effect of *SLC30A10* genotypic variance on gene expression levels would most likely be more pronounced in a tissue in which *SLC30A10* is highly expressed (eg, liver); however, liver samples were not available in this study. It should also be noted that the observed associations of genotypes with *SLC30A10* expression levels could be a secondary effect of their influence on Mn concentrations, which in turn could affect *SLC30A10* expression.

These SNPs are non-coding and appeared to influence *SLC30A10* transcript levels, indicating that, instead of affecting SLC30A10 protein function, they may be situated in gene regulatory elements and influence gene expression. Regulatory elements, eg, enhancers, are commonly found within intronic regions, where they can influence promoter activity via physical interactions mediated by transcription factors ([@kfv252-B5]). SNPs within such intronic regulatory elements can alter the binding affinity of transcription factors and affect promoter activity ([@kfv252-B35]; [@kfv252-B50]). Although elements involved in the regulation of transcription have also have been identified in 3′UTRs ([@kfv252-B14]), these sequences more commonly affect mRNA stability and post-translational regulation, eg, by the interaction with miRNAs. *In silico* analysis of these SNPs and immediate flanking regions did not reveal any non-coding RNA transcription, conserved miRNA binding sites, or 3′UTR sequence motifs that would indicate that they influence post-transcriptional regulation. However, publically available experimental data on the sequences nearest the 2 SNPs showed some regulatory activity of these regions, as observed by weak histone acetylation and DNase I hypersensitivity (rs12064812 only). *In silico* analysis revealed that for both SNPs, the 2 alleles generated different recognition sites for factors involved in transcriptional regulation. This is, however, merely an indication that the SNPs may affect transcriptional regulation, and should be investigated experimentally. It is also possible that the 2 selected SNPs in this study are not functional themselves, but instead tag functional SNPs by capturing genetic variation in a larger genetic region.

We further evaluated *SLC30A10* genotypes in association with neurological parameters related to Parkinsonism. We observed that the rs2275707 variant allele, which was associated with increased blood Mn concentrations, was also associated with increased sway velocity. The rs12064812 variant allele, which showed reduced Mn concentrations in blood, was associated with increased finger tapping speed. This is consistent with previous findings showing that higher blood Mn levels are associated with reduced finger-tapping speed ([@kfv252-B30]) and impaired postural balance (increased sway) ([@kfv252-B44]). Despite showing associations with *SLC30A10* genotypes, none of these parameters of neuromotor function were correlated with blood Mn concentrations, which may suggest that these associations are linked to a second level of SLC30A10-mediated Mn regulation that prevents excessive amounts of Mn from entering the brain. The SLC30A10 transporter is highly expressed in the CNS, particularly in the basal ganglia, where it likely acts to regulate brain Mn levels and thereby protect against the neurotoxic effects of Mn ([@kfv252-B36]). *SLC30A10* mutations that caused a dysfunctional SLC30A10 protein were also associated with Mn accumulation in the brain ([@kfv252-B48]).

Although SLC30A10 was originally identified as a Zn-transporter ([@kfv252-B45]), the structural features of this protein suggest that it could be specific to Mn transport ([@kfv252-B36]). This was further supported by the observation that patients with *SLC30A10* mutations have normal Zn levels ([@kfv252-B36]; [@kfv252-B48]). Also, the introduction of an *SLC30A10*-wt expression construct in HeLa cells caused reduced intracellular Mn levels but had no effect on Zn levels ([@kfv252-B21]). In this study, we did not observe any associations of *SLC30A10* genotypes on plasma Zn concentrations that would contradict the notion that the SCL30A10 protein functions as a specific Mn transporter.

In conclusion, this study shows that common non-coding genetic variation in the Mn transporter *SLC30A10* influences blood Mn concentrations in healthy individuals and that the association is likely to be mediated by altered levels of *SLC30A10* expression. We also show that genetic variants of *SLC30A10* influence neurological function independent of blood Mn concentrations, which indicates that SLC30A10 may play a role in the regulation of brain Mn levels. The hypothesis generated by this study is that a genetic predisposition caused by deficits in the SLC30A10 transporter in the brain and liver may contribute to an increased risk of Parkinsonism in populations environmentally exposed to Mn.
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###### Supplementary Data

[^1]: ^a^Sub-group with gene expression data.

[^2]: ^b^Measured in the Andean and Italian cohorts only.

[^3]: ^c^Mn concentrations in erythrocytes (µg/kg). For the Andean and Italian cohorts, the values were converted from total blood Mn (µg/l) based on the estimation that 66% of Mn in blood is bound to erythrocytes and that the density of the erythrocyte preparations were 1.055 g/ml. The volume fraction of erythrocytes in total blood for each individual was estimated by dividing their hemoglobin concentrations with the reference value of erythrocyte mean hemoglobin content of 340 g/l.

[^4]: ^d^Minor allele frequency for SNP.

[^5]: ^a^Percentage change in Mn concentrations (average) compared with homozygote for common allele.

[^6]: ^b^*P*-value for unadjusted linear model with ln-transformed Mn levels.

[^7]: ^c^*P*-value for adjusted linear model (age, gender, and ferritin) with ln-transformed Mn levels.

[^8]: \*Statistical significance.

[^9]: ^a^Percentage change in Zn concentrations (average) compared with homozygote for common allele.

[^10]: ^b^*P*-value for unadjusted linear model.

[^11]: ^c^*P*-value for adjusted linear model (age and gender).

[^12]: ^a^Percentage change in gene-expression (average) compared with homozygote for common allele.

[^13]: ^b^*P*-value for unadjusted linear model.

[^14]: ^c^*P*-value for adjusted linear model (age and ferritin).

[^15]: \*Statistical significance

[^16]: ^a^Mean value for group

[^17]: ^b^Percentage change in Mn concentrations (average) compared with homozygote for common allele.

[^18]: ^c^*P*-value for unadjusted linear model.

[^19]: ^d^*P*-value for adjusted linear model (age, gender).

[^20]: \*Statistical significance.
